You are here: Home

Personalized Medicine Today


Proventys, Inc. is a personalized medicine knowledge service provider focused on delivering cutting-edge risk prediction technology to power personalized clinical decisions at the point of care.  Through its proprietary risk assessment architecture, the company is able to harness the power of clinical data along with emerging diagnostic tests, including biomarkers from the fields of genomics, proteomics, and metabolomics, to power personalized medicine at the point of care.  This breakthrough enables clinicians to select more effective, targeted approaches to improve clinical and economic outcomes for each individual patient.

Prospective Medicine


Advances in diagnostic tests, new biomarkers, and genomic discoveries provide physicians the hope of evolving from today's reactive approach into the world of preventative, personalized health care, also known as prospective medicine.

How quickly we get there requires a committed effort to harness emerging diagnostics with the latest reliable clinical research databases to make personalized risk assessments.
[more]

Current Events and Publications



Proventys closes 5.65M in Series A1 funding; Announces New CEO. [more]